Joseph G. Rogers, MD

Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail Box 3034 DUMC, Durham, NC 27710
Phone (919) 681-3422
Email address joseph.rogers@duke.edu

My research interests are focused on clinical aspects of advanced heart failure. Specifically, I have investigative interests in pharmacologic and electrical treatments of systolic heart failure, the use of mechanical circulatory support devices, cardiac transplantation, and palliative care.

In Their Words

Education and Training

  • Fellow in Cardiology, Medicine, Washington University in St. Louis, 1991 - 1995
  • Medical Resident, Medicine, University of Nebraska Omaha, 1988 - 1991
  • M.D., University of Nebraska Omaha, 1988

Publications

Campbell, Lacey G., Sabarinathan Ramachandran, Wei Liu, J Michael Shipley, Shigeyoshi Itohara, Joseph G. Rogers, Nader Moazami, Robert M. Senior, and Andrés Jaramillo. “Different roles for matrix metalloproteinase-2 and matrix metalloproteinase-9 in the pathogenesis of cardiac allograft rejection.” Am J Transplant 5, no. 3 (March 2005): 517–28. https://doi.org/10.1111/j.1600-6143.2005.00744.x.

PMID
15707406
Full Text

Katsiyiannis, William T., Alan D. Waggoner, Benico Barzilai, Brian F. Gage, Jose M. Sanchez, Joseph G. Rogers, Bruce D. Lindsay, and Marye J. Gleva. “Simplified peak power reserve in patients with an implantable cardioverter-defibrillator and advanced heart failure.” Am J Cardiol 95, no. 2 (January 15, 2005): 286–88. https://doi.org/10.1016/j.amjcard.2004.09.020.

PMID
15642573
Full Text

Shah, Nirav R., Joseph G. Rogers, Gregory A. Ewald, Michael K. Pasque, Edward M. Geltman, Marci S. Bailey, and Nader Moazami. “Survival of patients removed from the heart transplant waiting list.” J Thorac Cardiovasc Surg 127, no. 5 (May 2004): 1481–85. https://doi.org/10.1016/j.jtcvs.2003.12.024.

PMID
15116011
Full Text

Rovner, Aleksandr, Srihari Thanigaraj, Joseph G. Rogers, Nader Moazami, and John M. Lasala. “Spontaneous multivessel coronary artery dissection in a young asymptomatic patient.” J Interv Cardiol 17, no. 2 (April 2004): 123–27. https://doi.org/10.1111/j.1540-8183.2004.00360.x.

PMID
15104776
Full Text

Doshi, Amit A., Joseph Rogers, Morton J. Kern, and Paul J. Hauptman. “Effectiveness of percutaneous coronary intervention in cardiac allograft vasculopathy.” Am J Cardiol 93, no. 1 (January 1, 2004): 90–92. https://doi.org/10.1016/j.amjcard.2003.08.075.

PMID
14697475
Full Text

Felker, G Michael, Adrian F. Hernandez, Joseph G. Rogers, Stuart D. Russell, Nancy L. Reinsmoen, Paul Rosenberg, Jonathan A. Hata, Andrew J. Lodge, and Carmelo A. Milano. “Cardiac transplantation at Duke University Medical Center.” Clin Transpl, 2004, 235–41.

PMID
16704154
Scholars@Duke

Yamada, Kathryn A., Joseph G. Rogers, Rune Sundset, Thomas H. Steinberg, and Jeffrey E. Saffitz. “Up-regulation of connexin45 in heart failure.” J Cardiovasc Electrophysiol 14, no. 11 (November 2003): 1205–12. https://doi.org/10.1046/j.1540-8167.2003.03276.x.

PMID
14678136
Full Text

Peterson, Linda R., Kenneth B. Schechtman, Gregory A. Ewald, Edward M. Geltman, Lisa de las Fuentes, Timothy Meyer, Pamela Krekeler, Martha L. Moore, and Joseph G. Rogers. “Timing of cardiac transplantation in patients with heart failure receiving beta-adrenergic blockers.” J Heart Lung Transplant 22, no. 10 (October 2003): 1141–48. https://doi.org/10.1016/s1053-2498(02)01225-1.

PMID
14550824
Full Text

Peterson, Linda R., Kenneth B. Schechtman, Gregory A. Ewald, Edward M. Geltman, Timothy Meyer, Pamela Krekeler, and Joseph G. Rogers. “The effect of beta-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure.” J Heart Lung Transplant 22, no. 1 (January 2003): 70–77. https://doi.org/10.1016/s1053-2498(02)00473-4.

PMID
12531415
Full Text

Pages